NCT04185454View on ClinicalTrials.gov

Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

April 15, 2019

Study Completion Date

April 15, 2019

Conditions
Heathy WomenPre Menopausal AgeExlution Criteria: Gastrointestinal DisorderLiver DiseaseDiabetesCancerKidney Disorder
Interventions
DIETARY_SUPPLEMENT

Jarlsberg cheese

Daily intake of Jarlsberg cheese

Trial Locations (1)

2013

Skjetten Legesenter, Skjetten

All Listed Sponsors
collaborator

Tine

INDUSTRY

lead

Prof Stig Larsen

OTHER

NCT04185454 - Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese | Biotech Hunter | Biotech Hunter